State Ledger
Company profile

ONCOLYTICS BIOTECH INC CIK 1129928

Ticker
ONCY (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
San Diego, CA 92121
Fiscal year end
2025 (FY)
Market Data
Close
$0.47
Change
-$0.08
Change %
-15.13%
Volume
19,587

ONCY · trading date Oct 12, 2026 · previous close $0.56 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$28.76M
Total assets
$7.58M
Total liabilities
$11.38M
Stockholders' equity
-$3.80M
Cash & equivalents
$5.20M
Operating income
-$28.73M
Operating cash flow
-$20.11M
Capital expenditures
$6.0K

Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$20.12M
Free cash flow margin
—
Liabilities / assets
150.1%
Equity / assets
-50.1%
CapEx / revenue
—
Operating cash flow / net income
0.70×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$28.76M $7.58M $11.38M -$3.80M
2024 — -$22.79M $13.42M $10.12M $3.30M
Company Details
SIC code
2834
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-10
Financials filed via
Form 10-K
filed 2026-03-30

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
San Diego, CA 92121
SUITE 325, 4350 EXECUTIVE DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:15 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies